SONX (Sonendo) ROE % Adjusted to Book Value: -2,102.73% (As of Dec. 2024)


SONX Sonendo Inc SONX
47 GF Score
Price $0.60
View Full Analysis

What is Sonendo ROE % Adjusted to Book Value?

Sonendo SONX 47 ROE % Adjusted to Book Value is -2,102.73% as of Dec. 2024. GuruFocus rates SONX with a GF Score™ of 47/100.

Sonendo's ROE % for the quarter that ended in Dec. 2024 was -315.41%. Sonendo's PB Ratio for the quarter that ended in Dec. 2024 was 0.15. Sonendo's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -2,102.73%.

Sonendo ROE % Adjusted to Book Value Related Terms

Sonendo ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Sonendo's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonendo ROE % Adjusted to Book Value Chart

Sonendo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 -47.79 -159.99 -1,112.07

Sonendo Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -190.52 -249.17 -386.00 -614.94 -2,102.73

SONX vs DHAI, AFIB, ABT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Sonendo's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonendo ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonendo's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sonendo's ROE % Adjusted to Book Value falls into.


SONX
47GF Score
Sonendo Inc SONX
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonendo ROE % Adjusted to Book Value Calculation

Sonendo's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-166.81% / 0.15
=-1,112.07%

Sonendo's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-315.41% / 0.15
=-2,102.73%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -2,102.73% mean?
Sonendo (SONX) has a ROE % Adjusted to Book Value of -2,102.73% as of Dec. 2024. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Sonendo and its competitors.
Is Sonendo's ROE % Adjusted to Book Value too high?
Sonendo's current ROE % Adjusted to Book Value is -2,102.73%. Overall, Sonendo has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Sonendo's ROE % Adjusted to Book Value compare to DHAI and AFIB?
Sonendo's ROE % Adjusted to Book Value of -2,102.73% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Sonendo and its competitors. Sonendo's current ROE % Adjusted to Book Value is -2,102.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonendo stock overvalued right now?
Sonendo (SONX) has a current ROE % Adjusted to Book Value of -2,102.73%. The current ROE % Adjusted to Book Value is -2,102.73%. Sonendo's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Sonendo (SONX), the current ROE % Adjusted to Book Value is -2,102.73% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sonendo Business Description

Address 26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
47GF Score

Get the complete analysis for SONX

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price